Shepherd Financial Partners LLC Sells 100 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Shepherd Financial Partners LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.7% in the 4th quarter, HoldingsChannel.com reports. The firm owned 5,776 shares of the healthcare conglomerate’s stock after selling 100 shares during the period. Shepherd Financial Partners LLC’s holdings in UnitedHealth Group were worth $2,922,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Kathleen S. Wright Associates Inc. purchased a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $27,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group in the 4th quarter worth $30,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of UnitedHealth Group during the third quarter worth about $37,000. Friedenthal Financial bought a new position in UnitedHealth Group during the 3rd quarter valued at approximately $51,000. Finally, Highline Wealth Partners LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter worth approximately $55,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $526.68 on Friday. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm’s 50-day moving average price is $530.85 and its 200-day moving average price is $564.52. The company has a market cap of $484.69 billion, a PE ratio of 33.98, a PEG ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $5.83 earnings per share. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts have issued reports on the stock. Wells Fargo & Company reduced their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a research note on Friday, January 10th. Barclays dropped their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. Finally, Truist Financial dropped their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.